Aranesp Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
Condition:   Myelodysplastic Syndromes Interventions:   Drug: Canakinumab Injection;   Drug: Darbepoetin Alfa Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Novartis Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2021 Category: Research Source Type: clinical trials

The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp
Condition:   Erythropoietin Adverse Reaction Intervention:   Drug: Acetylsalicylic acid Sponsor:   Zealand University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2020 Category: Research Source Type: clinical trials